BB Biotech as of Dec. 31, 2011
Portfolio Holdings for BB Biotech
BB Biotech holds 20 positions in its portfolio as reported in the December 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 21.3 | $189M | 2.8M | 67.60 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 11.2 | $100M | 3.0M | 33.21 | |
| Gilead Sciences (GILD) | 9.0 | $80M | 2.0M | 40.93 | |
| Incyte Corporation (INCY) | 8.6 | $76M | 5.1M | 15.01 | |
| ISIS Pharmaceuticals | 5.9 | $52M | 7.2M | 7.21 | |
| Micromet | 5.4 | $48M | 6.7M | 7.19 | |
| ImmunoGen | 5.2 | $46M | 4.0M | 11.58 | |
| Halozyme Therapeutics (HALO) | 5.1 | $46M | 4.8M | 9.51 | |
| Ariad Pharmaceuticals | 4.5 | $40M | 3.3M | 12.25 | |
| BioMarin Pharmaceutical (BMRN) | 3.8 | $34M | 976k | 34.38 | |
| Alexion Pharmaceuticals | 3.6 | $32M | 450k | 71.50 | |
| Amylin Pharmaceuticals | 3.1 | $27M | 2.4M | 11.38 | |
| Pharmasset | 2.2 | $19M | 150k | 128.20 | |
| Theravance | 2.1 | $19M | 843k | 22.10 | |
| Idenix Pharmaceuticals | 2.1 | $19M | 2.5M | 7.45 | |
| Optimer Pharmaceuticals | 2.0 | $18M | 1.4M | 12.24 | |
| Achillion Pharmaceuticals | 1.8 | $16M | 2.1M | 7.62 | |
| Human Genome Sciences | 1.7 | $15M | 2.0M | 7.39 | |
| Dendreon Corporation | 1.3 | $12M | 1.5M | 7.60 | |
| Endocyte | 0.3 | $2.6M | 702k | 3.76 |
